• Home
  • High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial.

High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial.

Author List
Tempero M, Leichner P, Baranowska-Kortylewicz J, Harrison K, Augustine S, Schlom J, Anderson J, Wisecarver J, Colcher D
Publication
Clinical cancer research : an official journal of the American Association for Cancer Research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1421399
Publication Year
2000
PubMed ID
10955789
Publication Title
Tempero M, Leichner P, Baranowska-Kortylewicz J, Harrison K, Augustine S, Schlom J, Anderson J, Wisecarver J, Colcher D. High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial. Clin Cancer Res. 2000 Aug; 6(8):3095-102.